Inflammation and Vascular Calcification Causing Effects of Oxidized HDL are Attenuated by Adiponectin in Human

Noor Hanisa Harun1, Gabriele Ruth Anisah Froemming2, Hapizah Md Nawawi1,3

  • 1Faculty of Medicine, Universiti Teknologi MARA, Cawangan Selangor, Sungai Buloh Campus, Selangor, Malaysia.

Insights

Oxidized high-density lipoprotein (oxHDL) promotes vascular calcification and inflammation. Adiponectin protects against these detrimental effects by suppressing oxHDL-induced changes in human vascular smooth muscle cells.

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Biochemistry

Background:

  • The role of oxidized high-density lipoprotein (oxHDL) in vascular calcification is unclear.
  • Adiponectin's protective mechanisms against oxHDL-induced vascular damage require further investigation.

Purpose of the Study:

  • To investigate the effects of oxHDL on inflammation and vascular calcification.
  • To determine if adiponectin can attenuate the detrimental effects of oxHDL.

Main Methods:

  • Human aortic vascular smooth muscle cells (HAoVSMCs) were treated with oxHDL and/or adiponectin.
  • Assays for cell viability, mineralization, and calcification were performed.
  • Protein expression of key inflammatory and osteogenic markers was measured using ELISA kits.

Main Results:

  • Oxidized high-density lipoprotein (oxHDL) induced vascular calcification and increased secretion of IL-6, osterix, WNT-5a, and NF-κβ(p65).
  • Adiponectin suppressed oxHDL-induced vascular calcification, inflammation, and osteogenic marker expression.
  • Adiponectin alone reduced inflammatory cytokines and osteoblastic markers in HAoVSMCs.

Conclusions:

  • Oxidized high-density lipoprotein (oxHDL) plays a significant role in inducing vascular inflammation and calcification.
  • Adiponectin demonstrates a protective effect by attenuating the adverse impacts of oxHDL on vascular cells.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
680
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
297
Inflammation01:38

Inflammation

Overview
61.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
789
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
268
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
6.1K